Stereotactic Body Radiotherapy for Liver Tumors
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Liver Metastases and Primary Liver Tumors
Sponsor: Mercy Research
This NA trial investigates Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma and is currently completed. Mercy Research leads this study, which shows 11 recorded versions since 2008 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Apr 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Apr 2020 [monthly]
Completed NA
-
Feb 2018 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed · Phase: PHASE4 → NA
-
Feb 2017 — Feb 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Sep 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mercy Research
For direct contact, visit the study record on ClinicalTrials.gov .